Gyrodyne , LLC (NASDAQ:GYRO – Get Free Report) was the target of a large growth in short interest in June. As of June 15th, there was short interest totaling 805 shares, a growth of 400.0% from the May 31st total of 161 shares. Based on an average daily volume of 2,212 shares, the days-to-cover ratio is currently 0.4 days. Currently, 0.0% of the company’s shares are sold short.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently made changes to their positions in the company. Advisory Services Network LLC bought a new position in shares of Gyrodyne in the 3rd quarter worth approximately $77,000. Susquehanna International Group LLP bought a new position in Gyrodyne in the third quarter worth $142,000. Teton Advisors LLC purchased a new position in Gyrodyne during the third quarter valued at $177,000. Finally, Bulldog Investors LLP bought a new stake in shares of Gyrodyne during the 3rd quarter valued at $601,000. Hedge funds and other institutional investors own 71.36% of the company’s stock.
Gyrodyne Trading Down 0.1%
Shares of NASDAQ:GYRO traded down $0.00 on Friday, hitting $6.13. The company had a trading volume of 139 shares, compared to its average volume of 1,640. The firm’s 50-day simple moving average is $6.95 and its two-hundred day simple moving average is $8.10. Gyrodyne has a 1 year low of $6.00 and a 1 year high of $12.00.
Gyrodyne Company Profile
Gyrodyne Company of America, Inc is a New York–based real estate investment and development firm specializing in medical office buildings and professional facilities. Listed on the NASDAQ under the ticker GYRO, the company’s principal business activity is the ownership, leasing and management of commercial properties tailored to healthcare and life sciences tenants. By focusing on outpatient diagnostic and treatment centers, clinical laboratories and related professional suites, Gyrodyne generates steady rental income and seeks to provide purpose-built environments that meet the specific needs of medical practitioners and research organizations.
The company’s core property portfolio is anchored by an approximately 87-acre campus situated in Stony Brook, Long Island.
Featured Articles
- Five stocks we like better than Gyrodyne
- As Stablecoins Keep Growing, These 2 Stocks Benefit
- Apple Just Handed These 4 Memory Stocks Their Best News of the Year
- Costco’s Secret Growth Engine May Be Running Out of Gas
- Why Alphabet’s Pullback May Be an Opportunity in Disguise
Receive News & Ratings for Gyrodyne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gyrodyne and related companies with MarketBeat.com's FREE daily email newsletter.
